China Supply Chain Progress Still Hampered by Corruption, Pollution, Working Conditions
Supply chains risks in China still include extremely high levels of corruption, environmental pollution issues and slow working conditions reforms, according to new analysis from Sedex.
Supply chains risks in China still include extremely high levels of corruption, environmental pollution issues and slow working conditions reforms, according to new analysis from Sedex.
While China remains “unparalleled in the region in terms of its productivity levels and speed at which deliveries can be turned around”, data from Sedex and global risk company Maplecroftpoint to continuing supply chain challenges such as health and safety issues, wages and working hours; inadequate storage and management of hazardous chemicals; and the sluggish progress of political liberalization.
“It is important that companies operating in the country understand the changing environment, with a growing middle class and changes in the availability of previously plentiful suppliers of cheap labor,” said Carmel Giblin, Sedex CEO. But the country’s main advantages remain its productivity levels and the speed at which deliveries can be turned around, which are “much, much better” than in countries such as Bangladesh and Cambodia, added Maplecroft’s Arvind Ramakrishnan.
Click here to download a copy of Sedex’s Responsible Sourcing Insights Briefings: China.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
